title: Turnover of peroxisomal vesicles by autophagic proteolysis in cultured fibroblasts from Zellweger patients.
abstract: Previous studies have shown that in fibroblasts from patients with the Zellweger syndrome (ZS) aberrant membrane structures are present which contain peroxisomal membrane proteins (Santos, M. J. et al., Science 239, 1536-1538 (1988)). In order to characterize these structures we have performed double labeling immunoelectron microscopy experiments using antisera directed against the 69 kDa peroxisomal integral membrane protein (PMP) and lysosomal hydrolases. The results indicate that at least 80% of the structures earlier referred to as 'peroxisomal ghosts' contain lysosomal hydrolases. In addition, we have studied the effect of culture of ZS fibroblasts in the presence of 3-methyladenine, an inhibitor of autophagy, on the intracellular distribution of the 69 kDa PMP. Immunofluorescence experiments showed that in the presence of 3-methyladenine there is an increase in fluorescent spots and a change in the distribution of the spots from mainly perinuclear to randomly distributed throughout the cytoplasm. Double labeling immunoelectron microscopy revealed that after culture in the presence of 3-methyladenine the 69 kDa PMP also accumulates mainly in compartments containing lysosomal hydrolases. In one ZS cell line we found that after culture in the presence of 3-methyladenine there was also an accumulation of structures which were as small as normal microperoxisomes. We conclude that in ZS fibroblasts the 69 kDa PMP is mainly present in lysosomal compartments, presumably degradative autophagic vacuoles. Furthermore, in ZS fibroblasts peroxisomes of apparently normal morphology may be synthesized, but they are degraded by autophagic proteolysis.
authors.affiliation: E. C. Slater Institute for Biochemical Research, University of Amsterdam, The Netherlands.
authors.forename: J C
authors.initials: JC
authors.lastname: Heikoop
authors.forename: M
authors.initials: M
authors.lastname: van den Berg
authors.forename: A
authors.initials: A
authors.lastname: Strijland
authors.forename: P J
authors.initials: PJ
authors.lastname: Weijers
authors.forename: W W
authors.initials: WW
authors.lastname: Just
authors.forename: A J
authors.initials: AJ
authors.lastname: Meijer
authors.forename: J M
authors.initials: JM
authors.lastname: Tager
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives / Q000494:pharmacology; D001343:Autophagy / Q000187:drug effects / Q000502:physiology*; D002460:Cell Line; D005347:Fibroblasts / Q000502:physiology* / Q000648:ultrastructure; D005455:Fluorescent Antibody Technique; D006801:Humans; D006867:Hydrolases / Q000032:analysis; D007976:Leupeptins / Q000494:pharmacology; D008247:Lysosomes / Q000201:enzymology; D008565:Membrane Proteins / Q000032:analysis; D008830:Microbodies / Q000737:chemistry / Q000502:physiology*; D015211:Zellweger Syndrome / Q000503:physiopathology*
chemical_list: D007976:Leupeptins; D008565:Membrane Proteins; C025946:3-methyladenine; D006867:Hydrolases; C032854:leupeptin; D000225:Adenine